Monograph

C10AA07 - Rosuvastatin

Propably not porphyrinogenic

Rationale

Low CYP-affinity. Probably not significantly metabolised

Chemical description

Statin type HMG-CoA reductase inhibitor used in treatment of hyperlipidemia, tabl. 30-120 mg/d. Distributed to the liver but metabolized only to a minor (10 %) extent. About 90 % of the dose is excreted in unchanged form infaeces. In vitro- and in vivo studies show that the substance is neither inhibitor , nor inducer of CYPs.

IPNet drug reports

Uneventful use reported in 31 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes C10A / C10AA or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames

Crestor · Provisacor · Rosuvastatine · Rovast

Crestor · Rosuvastatin · Rosuvastatine

Abemax · Alcotina · Alzil · Alzil 5 · Arrox · Arrox 5 · Crestor · Kastia · Provisacor · Rosuvastatina · Rosuvastatina usv · Roxera · Vaxar · Vaxar 5 · Ycomwya

Borghes · Colcardiol · Colfri · Crativ · Crestor · Exorta · Koleklin · Koleros · Lipidover · Miastina · Provisacor · Rosastin · Rosuberol · Rosuvastatina · Simestat · Snaptag · Staros · Tasavos · Tekvas